Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rank in Stocks #27034
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynรณw Lรณdzki, Poland.
Share Price
$2.21
Market Cap
$35.76M
Change (1 day)
2.88%
Change (1 year)
-15.27%
Country
PL
Trade Mabion S.A. (MAB)

Category

EPS for Mabion S.A. (MAB)
EPS as of 2026 TTM: 0
According to Mabion S.A. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Mabion S.A. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$-7.98 -
US
$27.74 -
NL
$2.98 -
AU
- -
CH